Back to News
Congressman Auchincloss questioned Secretary Kennedy about FDA's fast-tracking of psychedelics amidst alleged political pressures.
Quiver AI Summary
Congressman Auchincloss questions FDA leadership: Congressman Jake Auchincloss addressed Health and Human Services Secretary Robert F. Kennedy Jr. about recent FDA decisions to expedite psychedelic approvals, citing political influence. He referenced communications implying that White House pressure impacted these decisions, which had previously been denied.
Whistleblower disclosures cited: Auchincloss presented disclosures from FDA staff suggesting concerns over political interference compromising scientific integrity within the agency. He emphasized that the expedited drug approvals may prioritize political ties over public health standards.
Contentious exchange at hearing: During the hearing, Auchincloss challenged Kennedy's claims regarding decision-making processes, asserting evidence of political shortcuts bypassing established scientific protocols, particularly in fast-tracked psychedelic approvals linked to past discussions involving public figures.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Jake Auchincloss Fundraising
Jake Auchincloss recently disclosed ...
Read Full Story:
https://news.google.com/rss/articles/CBMi_gFBVV95cUxQUFhGdHZoWGJFS1ZiWnZNYTJ5...